SCHEMBL25002803

SCHEMBL25002803

CC(C)N1CCN(I)CC1CF

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20314967 0.78 PKM (0.31) PKM
SCHEMBL25001801 0.78 PKM (0.31) PKM
SCHEMBL24449009 0.76 PKM (0.38) PKM
SCHEMBL25002752 0.74
SCHEMBL18269013 0.73
SCHEMBL25773782 0.73
SCHEMBL18269014 0.73
SCHEMBL16285867 0.69 CHRM3 (0.35)
SCHEMBL21567149 0.69 CHRM3 (0.35)
SCHEMBL14626849 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4129996-A1 NOVEL AMINOPYRIMIDINE EGFR INHIBITOR QILU PHARMACEUTICAL CO., LTD. (CN) 2023-02-08 EP disclosed